Zacks Investment Research
News Agency

Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates
Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.88 per share, missing the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $3.28 per share a year ago.
Related Symbols
1
R
RIGL
RIGL
Source:
Zacks Investment Research
Visit Source
Comments